About us   Products   News archive   Sitemap   Links   Contact us  

    

Gucci Belt Best Quality

Gucci Belt Best Quality

Gucci Belt Best Quality

Gucci Belt Best Quality

Patent and Trademark Office has issued patent number 7,901,879, entitled, "Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases." The patent, which has a term until 2025, covers the use of oral human lactoferrins, including talactoferrin, for the treatment of non small cell lung cancer (NSCLC) and renal cell carcinoma. We are pleased to have recently completed enrollment in the FORTIS Belt Michael Kors

Agennix AG Announces Issuance of U S Patent Covering Use of Talactoferrin to Treat Non Small Cell Lung Cancer and Renal Cell Carcinoma

Agennix also reported that a patent application covering the use of talactoferrin in lung cancer has recently received a Decision to Grant in Japan. This patent would provide protection until 2023. Talactoferrin has demonstrated promising activity in randomized, double blind, placebo controlled Phase II studies in NSCLC, as well as in severe sepsis. Two Phase III trials with talactoferrin in NSCLC are ongoing, and one the FORTIS M trial completed enrollment in March 2011. NSCLC is one of the most common types of cancer worldwide and the most frequent cause of cancer death. Agennix also plans to develop talactoferrin further for the treatment of severe sepsis and plans to initiate a Phase II/III trial in that indication. The Company's most advanced program is talactoferrin, an oral therapy that has demonstrated activity in randomized, double blind, placebo controlled Phase II studies in non small cell lung cancer, as well as in severe sepsis. Talactoferrin is currently in Phase III clinical trials in non small cell lung cancer, and Agennix plans to develop this program further for the treatment of severe sepsis. Other clinical development programs include RGB 286638, a multi targeted kinase inhibitor in Phase I testing, and a topical gel form of talactoferrin for diabetic foot ulcers. Agennix's registered seat is in Heidelberg, Germany. The Company has three sites of operation: Planegg/Munich, Germany; Princeton, New Jersey and Houston, Texas.

Gucci Belt Best Quality

Gucci Belt Best Quality

Gucci Belt Best Quality

Gucci Belt Best Quality

and Agennix undertakes no obligation to update these forward looking statements, even if new information becomes available in the future.

M Phase III registration trial evaluating talactoferrin Gucci Belt Best Quality for this use."

Gucci Belt Best Quality

made Lv Belt Gold Buckle

Gucci Belt Best Quality

Gucci Belt Best Quality

This press release contains forward looking statements, which express the current beliefs and expectations of the management of Agennix AG. Such statements are based on current expectations and are subject to risks and uncertainties, many of which are beyond our control, that could cause future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward looking statements. Actual results could differ materially depending on a number of factors, and we caution investors not to place undue reliance on the forward looking statements contained in this press release. There can be no guarantee that talactoferrin will be approved for marketing for non small cell lung cancer or any other indication in a timely manner, if at all. Forward looking statements speak only as of the date on which they are Michael Kors Belt Red

Gucci Belt Best Quality

Louis Vuitton Belt Gold Plated

Mk Bags Leather
Gucci Belt Green Red Gold

Mk Bags Latest Collection
Gucci Belt Drawing

Michael Kors Ava Gold
Gucci Belt Mens Ebay

Gucci Belt Gg Men

Gucci Belt Tiger Buckle

Hermes Belt Cheap

Michael Kors White Purse
Hermes Belt Men Original

Michael Kors Bags For Women 2018
Lv Belts For Sale

Gucci Belt Women

Home / Gucci Belt Best Quality